Stifel Financial’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $508K | Buy |
9,008
+2,057
| +30% | +$134K | ﹤0.01% | 2874 |
|
|
2025
Q4 | $557K | Sell |
6,951
-7,957
| -53% | -$535K | ﹤0.01% | 2797 |
|
|
2025
Q3 | $727K | Sell |
14,908
-880
| -6% | -$54.5K | ﹤0.01% | 2584 |
|
|
2025
Q2 | $1.18M | Sell |
15,788
-26
| -0.2% | -$1.72K | ﹤0.01% | 2226 |
|
|
2025
Q1 | $1M | Buy |
15,814
+1,038
| +7% | +$70.6K | ﹤0.01% | 2230 |
|
|
2024
Q4 | $1.15M | Buy |
14,776
+1,006
| +7% | +$80.8K | ﹤0.01% | 2161 |
|
|
2024
Q3 | $1.11M | Buy |
13,770
+6,425
| +87% | +$519K | ﹤0.01% | 2163 |
|
|
2024
Q2 | $608K | Buy |
7,345
+2,132
| +41% | +$188K | ﹤0.01% | 2505 |
|
|
2024
Q1 | $445K | Buy |
5,213
+65
| +1% | +$5.1K | ﹤0.01% | 2686 |
|
|
2023
Q4 | $440K | Buy |
5,148
+346
| +7% | +$29.9K | ﹤0.01% | 2637 |
|
|
2023
Q3 | $430K | Sell |
4,802
-18
| -0.4% | -$1.61K | ﹤0.01% | 2579 |
|
|
2023
Q2 | $410K | Sell |
4,820
-71
| -1% | -$6K | ﹤0.01% | 2635 |
|
|
2023
Q1 | $405K | Buy |
4,891
+119
| +2% | +$9.63K | ﹤0.01% | 2637 |
|
|
2022
Q4 | $375K | Sell |
4,772
-115
| -2% | -$9.24K | ﹤0.01% | 2631 |
|
|
2022
Q3 | $362K | Sell |
4,887
-2,138
| -30% | -$154K | ﹤0.01% | 2627 |
|
|
2022
Q2 | $458K | Sell |
7,025
-2,071
| -23% | -$123K | ﹤0.01% | 2509 |
|
|
2022
Q1 | $575K | Buy |
9,096
+101
| +1% | +$5.49K | ﹤0.01% | 2493 |
|
|
2021
Q4 | $477K | Sell |
8,995
-3,815
| -30% | -$232K | ﹤0.01% | 2615 |
|
|
2021
Q3 | $904K | Sell |
12,810
-12,706
| -50% | -$802K | ﹤0.01% | 2172 |
|
|
2021
Q2 | $1.7M | Buy |
25,516
+4,082
| +19% | +$289K | ﹤0.01% | 1723 |
|
|
2021
Q1 | $2.38M | Buy |
21,434
+82
| +0.4% | +$10.1K | ﹤0.01% | 1417 |
|
|
2020
Q4 | $2.54M | Buy |
21,352
+1,044
| +5% | +$112K | ﹤0.01% | 1246 |
|
|
2020
Q3 | $1.77M | Buy |
20,308
+12,997
| +178% | +$1.14M | ﹤0.01% | 1280 |
|
|
2020
Q2 | $655K | Buy |
7,311
+2,970
| +68% | +$300K | ﹤0.01% | 1847 |
|
|
2020
Q1 | $434K | Sell |
4,341
-2,603
| -37% | -$282K | ﹤0.01% | 1953 |
|
|
2019
Q4 | $793K | Sell |
6,944
-661
| -9% | -$80K | ﹤0.01% | 1987 |
|
|
2019
Q3 | $964K | Buy |
7,605
+4,521
| +147% | +$574K | ﹤0.01% | 1776 |
|
|
2019
Q2 | $371K | Sell |
3,084
-4,322
| -58% | -$425K | ﹤0.01% | 2367 |
|
|
2019
Q1 | $645K | Sell |
7,406
-1,144
| -13% | -$104K | ﹤0.01% | 1916 |
|
|
2018
Q4 | $862K | Buy |
8,550
+5,070
| +146% | +$533K | ﹤0.01% | 1631 |
|
|
2018
Q3 | $399K | Sell |
3,480
-9,300
| -73% | -$963K | ﹤0.01% | 2197 |
|
|
2018
Q2 | $1.15M | Buy |
12,780
+123
| +1% | +$10.4K | ﹤0.01% | 1526 |
|
|
2018
Q1 | $929K | Buy |
12,657
+43
| +0.3% | +$2.95K | ﹤0.01% | 1611 |
|
|
2017
Q4 | $732K | Sell |
12,614
-177
| -1% | -$9.32K | ﹤0.01% | 1711 |
|
|
2017
Q3 | $574K | Buy |
12,791
+867
| +7% | +$36K | ﹤0.01% | 1803 |
|
|
2017
Q2 | $470K | Buy |
11,924
+2,675
| +29% | +$110K | ﹤0.01% | 1903 |
|
|
2017
Q1 | $376K | Sell |
9,249
-48
| -0.5% | -$1.88K | ﹤0.01% | 1975 |
|
|
2016
Q4 | $372K | Sell |
9,297
-3,299
| -26% | -$124K | ﹤0.01% | 1929 |
|
|
2016
Q3 | $457K | Sell |
12,596
-4,152
| -25% | -$143K | ﹤0.01% | 1769 |
|
|
2016
Q2 | $486K | Sell |
16,748
-857
| -5% | -$25.9K | ﹤0.01% | 1770 |
|
|
2016
Q1 | $615K | Sell |
17,605
-503
| -3% | -$16.2K | ﹤0.01% | 1472 |
|
|
2015
Q4 | $583K | Buy |
18,108
+595
| +3% | +$19.3K | ﹤0.01% | 1577 |
|
|
2015
Q3 | $567K | Buy |
17,513
+958
| +6% | +$36.1K | ﹤0.01% | 1482 |
|
|
2015
Q2 | $686K | Buy |
16,555
+2,342
| +16% | +$98.7K | ﹤0.01% | 1521 |
|
|
2015
Q1 | $639K | Buy |
14,213
+7,055
| +99% | +$295K | ﹤0.01% | 1497 |
|
|
2014
Q4 | $268K | Sell |
7,158
-176
| -2% | -$6.45K | ﹤0.01% | 1934 |
|
|
2014
Q3 | $256K | Buy |
+7,334
| New | +$262K | ﹤0.01% | 1874 |
|
Other funds holding HAE
VPM
VCM
RRAM
Stifel Financial's HAE Position: Q1 2026 in Review
Stifel Financial increased its Haemonetics (HAE) stake by 30% in Q1 2026, buying an estimated $134K and bringing the position to 9,008 shares worth $508K. The position accounts for ﹤0.01% of the portfolio, ranked #2874.
Stifel Financial first reported a position in HAE in Q3 2014 and has held it in 47 quarters since. The position peaked at $2.54M in Q4 2020. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Stifel Financial held 9,008 shares of Haemonetics worth $508K as of Q1 2026.
- Stifel Financial bought 2,057 Haemonetics shares in Q1 2026, an estimated $134K.
- Haemonetics made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2874 holding.
- Stifel Financial first reported a position in Haemonetics in Q3 2014 and has held it in 47 quarters since.
- Stifel Financial's Haemonetics position peaked at $2.54M in Q4 2020.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.